Search results
Moderna's RSV Vaccine Approved by FDA
Medscape· 2 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 4 days agoModerna's vaccine was approved by the FDA for the prevention of RSV-associated lower respiratory...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 4 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says
MedPage Today· 5 days agoData from the Vaccine Adverse Event Reporting System (VAERS) revealed that there were 1.5 reports of GBS per 1 million doses administered of the GSK RSV ...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 1 day agoSo investors today aren't viewing the vaccine as a growth product for the company. But this problem evaporated with the good news Moderna delivered a few...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 4 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoMeanwhile, Pfizer began testing its pandemic vaccine last year. Meanwhile, investors are closely...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 8 hours agoPfizer's Abrysvo is one of three new respiratory syncytial virus (RSV) vaccines approved to prevent...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 4 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 1 day agoLaunching mResvia won't be easy In May 2023, the FDA approved Arexvy, a respiratory syncytial virus...
